Epalex Corp announced it raised $20.3 Million in an amended filing from an offering of $20.3 Million
Epalex Corp announced it raised $20.3 Million in an amended filing from an offering of $20.3 Million
12/18/20, 10:13 PM
Location
mountain viewMoney raised
$20.3 million
Industry
healthcare
Company Info
Location
1049 el monte avenue, suite c 585
mountain view, california, united states
Additional Info
Epalex is a clinical-stage pharmaceutical company developing breakthrough therapies for people with migraines or epilepsy. The Epalex drug development candidates have a unique mechanism of action that is differentiated from existing therapies.